Member Info for Scoobydoo321

So overall, I get the gist (which could be completely wrong) that the TU in Feb 21 says it all, i.e.
- Wait for Covid to past - and then biz back to "normal". Until that time, we are getting ready....new U.S ceo.....building our white label biz + manuf facilities + new products in pipeline +cost savings + wadded up - but .... strong performance - only "expected" in the near future. ....
And it's a "buy in cheap whilst it's a bargain" kind of recovery stock.

Could it be the shareholders of the RTO company? Coz it's getting ludicrous now

@Jurado - why do you think TRX's results are going to be good and when are they expected to be released. Thanks.

So who has been selling and selling and selling .........even at these suppressed prices?

Gosh..it's woken up from its slumber! A few more months ...hopefuly FDA approval and voila .......the big time!

Well done Red knight for getting in early - you weighed the risks made the investment.

Per Finncap March 21 Notes - "4basebio is at the beginning of its valuation journey, and we believe it is
too early to provide a meaningful target price/valuation for the company. There are a
number of comparable companies, albeit more advanced, which provide an indication
of the potential future value. Based on these and discounting back to the present day,
it is possible to envisage the value of its technology rising to c.£75-100m in the near
term (GMP-grade DNA), which compares with its current EV of £26m."

IPO price was 12p - was it not?

@fizzydrinks - Are you wearing clothes? Then you are not all in. :)

@Chris5 - perhaps not and besides - it's also the MMer widening spreads that's making the diff.

@bots - per Feb TU

The Board will outline our growth plans for 2021 and beyond in more detail with the publication of our full year accounts, expected to be announced in May 2021."

Persistent seller - stopped selling ...their little tranches....

CFO (renown to be frugal) bought in circa 62-63p a few months back.

Significantly undervalued......and one of the few genuine Covid recovery plays around that remains at bargain prices.

Just tested with online broker -
Bid-Offer : 72.75-72.97 @ 8.42am

Very tight spread.

Also did not notice any delay sell orders on Friday. So overall, most encouraging....and so it should be ....completely undervalued.

Whoever wrote that RNS needs a course in copyrighting....absolutely poor standard of writing eroding shareholders value by >30%.

Excellent analysis here on CAPD
https://smallcapslife.substack.com/p/small-caps-live-weekly-summary-73a

@ Aberforth have increased above 11% - they now have almost 21.4m shares.

MV - CAPD - circa 125mn
Aberforth holding circa £14mn worth of CAPD shares
Indicates to me still scope to hoover more!

And at these prices....I know I would

@Cbax - nominated adviser

Guys - How does the court case on human rights , Tanzania affect PDL ? Can you share your insight. Cheers

Topped up 8am and another tranche - hopefully not a false dawn .........

Now HEAVE !!!!!!!!!!!!!